Care Homes
(asked on )
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what criteria his Department uses to decide whether to prescribe Kadcyla using funds from the Cancer Drugs Fund.
This question was answered on 6th May 2014
NHS England is responsible for administering the Cancer Drugs Fund. Its national Cancer Drugs Fund clinical panel added Kadcyla (trastuzumab emtansine) for the treatment of HER2-positive locally advanced/unresectable or metastatic breast cancer to its national cohort policies list in February 2014. Further information on how the panel made its decision is available at:
www.england.nhs.uk/ourwork/pe/cdf/